Infigratinib靶向的FGFR3（成纤维细胞生长因子受体3）正是驱动ACH疾病发生的关键靶点，2月12日，BridgeBio公布Infigratinib在ACH中取得的首个具有统计学显著改善意义的3期顶线结果，公司计划下半年向FDA提交新药申请。
Artemis 2 works toward April launchThe revised campaign comes as engineers work through immediate issues on Artemis II, the first crewed flight of the program. After a successful "wet dress rehearsal" — a full countdown test that loads the rocket with super‑cold fuel — teams discovered that helium was not flowing correctly to the engines in the rocket's upper stage.，详情可参考快连下载安装
。业内人士推荐91视频作为进阶阅读
Цены на нефть взлетели до максимума за полгода17:55
Владислав Уткин，推荐阅读旺商聊官方下载获取更多信息